Mitsubishi UFJ Asset Management’s Precision BioSciences DTIL Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,184	Closed	-$109K	–	1160
2022 Q1	$109K	Buy	1,184 +134	+13%	+$18.2K	﹤0.01%	1121
2021 Q4	$244K	Sell	1,050 -38	-3%	-$10.6K	﹤0.01%	1049
2021 Q3	$377K	Sell	1,088 -13	-1%	-$4.41K	﹤0.01%	979
2021 Q2	$414K	Sell	1,101 -151	-12%	-$45.4K	﹤0.01%	981
2021 Q1	$389K	Buy	1,252 +400	+47%	+$140K	﹤0.01%	922
2020 Q4	$213K	Buy	+852	New	+$209K	﹤0.01%	948

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mitsubishi UFJ Asset Management's DTIL Position: Q2 2022 in Review

Mitsubishi UFJ Asset Management sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 1,184 shares — an estimated $109K sold.

Mitsubishi UFJ Asset Management first reported a position in DTIL in Q4 2020 and held it in 6 quarters. The position peaked at $414K in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

Mitsubishi UFJ Asset Management reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
Mitsubishi UFJ Asset Management sold 1,184 Precision BioSciences shares in Q2 2022, an estimated $109K.
Mitsubishi UFJ Asset Management first reported a position in Precision BioSciences in Q4 2020 and held it in 6 quarters.
Mitsubishi UFJ Asset Management's Precision BioSciences position peaked at $414K in Q2 2021.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.